PRGO FY 2025 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

FY 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$4.3B-2.8% YoY

Gross Profit

$1.5B35.1% margin

Operating Income

$343M8.1% margin

Net Income

-$1.4B-33.5% margin

EPS (Diluted)

$-10.29

Cash Flow

Operating Cash Flow

$239M

Free Cash Flow

$145M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$8.5B

Total Liabilities

$5.6B

Stockholders' Equity

$2.9B

Cash & Equivalents

$532M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.3B	$4.4B	-2.8%
Gross Profit	$1.5B	$1.5B	-3.1%
Operating Income	$343M	$113M	+204.1%
Net Income	-$1.4B	-$172M	-729.7%